Summary
- Current Price
- As of today, TEVA price is $33.86, up +0.27% on
- Current Price All-Time High
- TEVA price is currently -53.17% below its historical high of $72.31 set on
- Market Cap
- TEVA current market cap is $39B, up +107.74% over the past 365 days
- PE Ratio
- TEVA current PE ratio is 27.80
- Revenue
- TEVA current annual revenue is $17.46B, up +5.26% year-over-year
- Next Earnings
- The next earnings release for TEVA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Teva Pharmaceutical Industries Limited |
| Ticker | NYSE: TEVA |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | tevapharm.com |
| Employees | 37,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $33.86 | |
| Price, 1D Change | +0.27% | |
| Market Cap | $39B | |
| TTM Dividend Yield | - | |
| PE Ratio | 27.80 | |
| Beta | 0.90 | |
| Revenue | $17B | |
| Revenue, 1Y Change | +5.26% | |
| EPS | $1.22 | |
| EPS, 1Y Change | +183.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.09 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.22 | |
| EPS Estimate | N/A | $2.68 |
| EPS Est. Change | N/A | +119.45% |
| Revenue | $17.46B | |
| Revenue Estimate | N/A | $16.60B |
| Revenue Est. Change | N/A | -4.90% |
| Current Price | $33.86 | |
| Price Target | - | $39.00 |
| Price Tgt. Change | - | +15.18% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.47 | -$1.46 | -158.96% | |
| $2.63 | $1.22 | -53.51% | |
| $2.68 | N/A | +119.45% | |
| $3.09 | N/A | +152.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.42B | $16.59B | +1.01% | |
| $16.91B | $17.46B | +3.27% | |
| $16.60B | N/A | -4.90% | |
| $17.16B | N/A | -1.70% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +107.48% | |
| Price, 3Y | +242.02% | |
| Market Cap, 1Y | +107.74% | |
| Market Cap, 3Y | +253.26% | |
| Revenue, 1Y | +5.26% | |
| Revenue, 3Y | +17.53% | |
| EPS, 1Y | +183.93% | |
| EPS, 3Y | +155.67% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $33.86 | |
| SMA 200 | $22.83 | |
| SMA 200 vs Price | -32.59% | |
| SMA 50 | $32.78 | |
| SMA 50 vs Price | -3.19% | |
| Beta | 0.90 | |
| ATR | $0.95 | |
| 14-Day RSI | 53.46 | |
| 10-Day Volatility | 11.53% | |
| 1-Year Volatility | 42.52% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.09 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $17.46B | |
| EPS | $1.22 | |
| Gross Profit | $8.97B | |
| Gross Margin | 51.56% | |
| Operating Profit | $3.98B | |
| Operating Margin | 22.90% | |
| Net Income | $1.43B | |
| Net Margin | 8.22% | |
| EBITDA | $4.99B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.16 | |
| 1.04 | ||
| 0.80 | ||
| - | ||
| 8 | ||
| 1.00 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 27.80 | |
| 2.23 | ||
| 4.91 | ||
| 10.48 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $7.91B | |
| $3.56B | ||
| $40.75B | ||
| $13.95B | ||
| $32.83B | ||
| $13.46B | ||
| Total Debt | $17.19B | |
| $1.82B | ||
| $2.53B |
Expenses
| Metric | Date | Value |
|---|---|---|
| $15.97B | ||
| $4.99B | ||
| $8.43B | ||
| $0.00 | ||
| $1.01B | ||
| $0.00 | ||
| -$181.43M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $2.89B | ||
| -$519.09M | ||
| -$2.13B | ||
| Capex | $504.97M | |
| $2.38B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Goldman Sachs | → | |
| Barclays | → | |
| Truist Securities | → | |
| Scotiabank | → | |
| Jefferies | → | |
| Piper Sandler | → | |
| Goldman Sachs | → | |
| JP Morgan | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with TEVA
FAQ
What is the ticker symbol for Teva Pharmaceutical Industries Limited?
The ticker symbol for Teva Pharmaceutical Industries Limited is NYSE:TEVA
Does Teva Pharmaceutical Industries Limited pay dividends?
No, Teva Pharmaceutical Industries Limited does not pay dividends
What sector is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Healthcare sector
What industry is Teva Pharmaceutical Industries Limited in?
Teva Pharmaceutical Industries Limited is in the Specialty & Generic Drug Manufacturers industry
What country is Teva Pharmaceutical Industries Limited based in?
Teva Pharmaceutical Industries Limited is headquartered in Israel
When did Teva Pharmaceutical Industries Limited go public?
Teva Pharmaceutical Industries Limited initial public offering (IPO) was on February 16, 1982
Is Teva Pharmaceutical Industries Limited in the S&P 500?
No, Teva Pharmaceutical Industries Limited is not included in the S&P 500 index
Is Teva Pharmaceutical Industries Limited in the NASDAQ 100?
No, Teva Pharmaceutical Industries Limited is not included in the NASDAQ 100 index
Is Teva Pharmaceutical Industries Limited in the Dow Jones?
No, Teva Pharmaceutical Industries Limited is not included in the Dow Jones index
When was Teva Pharmaceutical Industries Limited last earnings report?
Teva Pharmaceutical Industries Limited's most recent earnings report was on January 28, 2026
When does Teva Pharmaceutical Industries Limited report earnings?
The next expected earnings date for Teva Pharmaceutical Industries Limited is May 6, 2026
Data Sources & References
- TEVA Official Website www.tevapharm.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/818686/000117184326000462/0001171843-26-000462-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/818686/000119312526034532/0001193125-26-034532-index.htm
- TEVA Profile on Yahoo Finance finance.yahoo.com/quote/TEVA
- TEVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/teva